Recombinant EBOV (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) GP / Glycoprotein Protein (His Tag)

Introducing the Recombinant EBOV Glycoprotein, a highly advanced product that boasts exceptional quality and efficacy. This glycoprotein is derived from the Zaire subtype of the Ebola virus, specifically the H.sapiens-WT/GIN/2014/Kissidougou-C15 strain. The product is designed to provide a highly purified and stable form of the GP protein, which is essential for the development of vaccines and diagnostic tools for the Ebola virus.

The Recombinant EBOV Glycoprotein is produced using state-of-the-art recombinant DNA technology, ensuring that the product is of the highest quality and purity. The protein is expressed in a mammalian cell system and is purified using a combination of chromatography and ultrafiltration techniques. The product is also tagged with a histidine (His) tag, which allows for easy purification and detection.

This product is ideal for researchers and scientists who are working on the development of vaccines and diagnostic tools for the Ebola virus. The Recombinant EBOV Glycoprotein is a highly reliable and consistent source of the GP protein, which is essential for the development of these products. The product is also suitable for use in a wide range of applications, including ELISA, Western blotting, and other immunoassays.

In summary, the Recombinant EBOV Glycoprotein is a highly advanced and reliable product that is essential for the development of vaccines and diagnostic tools for the Ebola virus. Its exceptional quality and efficacy make it an ideal choice for researchers and scientists who are working on this important area of research.